Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Bictegravir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021 4 0
Dolutegravir Potential treatment - theoretical effect Used to treat other disease Antiviral Jan/25/2021 5 0
Enalapril Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/28/2020 2 1
Cangrelor Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/24/2020 4 0
MT326715 Potential treatment - theoretical effect Experimental Vaccine Jun/17/2020 1 0
MT326102 Potential treatment - theoretical effect Experimental Vaccine Jun/17/2020 1 0
Fenbendazole Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020 1 0
Corilagin Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020 1 0
Excel (.xslx) CSV (.csv)